行情

SIBN

SIBN

SI-BONE
NASDAQ

实时行情|Nasdaq Last Sale

18.33
+0.13
+0.71%
盘后: 18.33 0 0.00% 16:00 12/06 EST
开盘
18.27
昨收
18.20
最高
18.53
最低
18.13
成交量
13.46万
成交额
--
52周最高
23.03
52周最低
14.08
市值
3.99亿
市盈率(TTM)
-12.6492
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SIBN 新闻

  • SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors
  • GlobeNewswire.2天前
  • SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019
  • GlobeNewswire.3天前
  • 报告:6家硅谷巨头过去10年全球避税1000亿美元
  • 新浪科技.3天前
  • 报告:秘鲁2019年三季度倒闭公司数量同比增五成
  • 中国新闻网.3天前

更多

所属板块

医疗设备、用品及经销
+0.61%
医疗设备和用品
+0.64%

热门股票

名称
价格
涨跌幅

SIBN 简况

SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.
展开

Webull提供SI-Bone Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。